economybharat.com

We Can Cover You
Click here
Facebook Youtube Instagram Linkedin
13
13

Elicera

Elicera Therapeutics’ drug candidate ELC-100 receives Orphan Drug Designation in the U.S. for the treatment of pancreatic neuroendocrine tumors

Elicera Therapeutics’ drug candidate ELC-100 receives Orphan Drug Designation in the U.S. for the treatment of pancreatic neuroendocrine tumors

creativebharatgroup@gmail.com January 13, 2025
Gothenburg, January 13, 2025 – Elicera Therapeutics AB (publ), a clinical stage cell and...
Read More Read more about Elicera Therapeutics’ drug candidate ELC-100 receives Orphan Drug Designation in the U.S. for the treatment of pancreatic neuroendocrine tumors